A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder



Status:Recruiting
Conditions:Depression, Depression, Major Depression Disorder (MDD)
Therapuetic Areas:Psychiatry / Psychology, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:18 - 65
Updated:2/17/2019
Start Date:July 13, 2018
End Date:September 2022

Use our guide to learn which trials are right for you!

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole as Adjunctive Therapy in the Maintenance Treatment of Adults With Major Depressive Disorder

Major depressive disorder (MDD) is a serious medical illness associated with significant
suicidal risk and marked disability. Despite the availability of numerous treatments,
achievement of consistent and favorable long-term outcomes remains challenging.

This study will assess the safety, efficacy and tolerability of brexpiprazole as adjunctive
therapy to protocol-specific open-label antidepressant therapy.


Inclusion Criteria:

- Subjects with both a diagnosis of recurrent major depressive disorder, and in a
current major depressive episode of ≥ 8 weeks in duration, as defined by Diagnostic
and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) and confirmed by both
the Mini International Neuropsychiatric Interview (MINI) and an adequate clinical
psychiatric evaluation.

- Subjects must have reported a history for the current major depressive episode of an
inadequate response to 1 or 2 adequate antidepressant treatments, and subjects must
currently be taking a protocol-mandated antidepressant treatment at an adequate dose
and duration, and most not have reported ≥ 50% improvement. For subjects who are
currently on an adequate dose of protocol-mandated antidepressant therapy (ADT), but
for an inadequate duration, can use the screening period to achieve adequate duration.
At Phase A baseline visit, all subjects must have either 2 or 3 documented inadequate
responses to antidepressant treatment in total for the current episode as defined by
the Massachusetts General Hospital Antidepressant Treatment Response Questionnaire
(ATRQ)

- Subjects with a Hamilton Rating Scale for Depression (HAM-D17) total score ≥ 18 at the
screening visit, and Phase A baseline visits.

- Subjects willing to discontinue all prohibited psychotropic medications to meet
protocol-required washouts prior to and during the trial period.

Exclusion Criteria:

- Females who are breast-feeding and/or who have a positive pregnancy test result prior
to receiving investigational medicinal product (IMP).

- Sexually active males or females of childbearing potential who do not agree to
practice 2 different methods of birth control or remain abstinent during the trial and
for 30 days after the last dose of IMP.

- Subjects who report treatment with adjunctive antipsychotic medication with an
antidepressant for a minimum of 3 weeks during the current major depressive episode

- Subjects who report allergies or an intolerability (lifetime treatment history) to
trial-provided ADTs that have not been prescribed to the subject during the current
major depressive episode.

- Subjects who have received ECT for the current major depressive episode

- Subjects who have had an inadequate response to ECT at any time in the past or who
have had a vagus nerve stimulation or deep brain stimulation device implanted at any
time for the management of treatment-resistant depression. Subjects who have had
transcranial magnetic stimulation during the current major depressive episode.

- Subjects with a current need for involuntary commitment or who have been hospitalized
within 4 weeks of screening for the current major depressive episode.

- Subjects with a primary DSM-5 diagnosis of:

1. Schizophrenia Spectrum and Other Psychotic Disorders

2. Bipolar and Related Disorders

3. Obsessive Compulsive Disorders

4. Feeding and Eating Disorders

5. Neurocognitive Disorders

6. Panic Disorder

7. Post-Traumatic Stress Disorder

- Subjects with a current DSM-5 diagnosis of borderline, antisocial, paranoid, schizoid,
schizotypal, or histrionic personality disorder or intellectual disability.

- Subjects experiencing hallucinations, delusions, or any psychotic symptomatology in
the current major depressive episode

- Subjects receiving new onset psychotherapy (individual, group, marriage or family
therapy) within 42 days of screening or at any time during participation in the trial

- Subjects who have met DSM-5 criteria for substance use disorder (moderate or severe)
within the past 60 days; including alcohol and benzodiazepines, but excluding nicotine

- Subjects with hypothyroidism or hyperthyroidism (unless condition has been stabilized
with medications for at least the past 90 days) and/or an abnormal result for free T4
at screening.

- Subjects who currently have clinically significant neurological, hepatic, renal,
metabolic, hematological, immunological, cardiovascular, pulmonary, or
gastrointestinal disorders such as any history of myocardial infarction, congestive
heart failure, HIV seropositive status/acquired immunodeficiency syndrome, chronic
hepatitis B or C.

- Subjects with diabetes mellitus (IDDM and non-IDDM) are ineligible for the trial
unless their condition is stable and well-controlled.

- Subjects with uncontrolled hypertension (DBP > 95 mmHg) or symptomatic hypotension, or
orthostatic hypotension which is defined as a decrease of ≥ 30 mmHg in SBP and/or
decrease of ≥ 20 mmHg in DBP after at least 3 minutes standing compared to the
previous supine blood pressure OR development of symptoms.

- Subjects with known ischemic heart disease or history of myocardial infarction-or
congestive heart failure (whether controlled or uncontrolled)

- Subjects with epilepsy or a history of seizures, except for a single seizure episode

- Subjects with a positive drug screen for cocaine or other drugs of abuse (excluding
known prescription stimulants and other medications and marijuana). Detectable levels
of alcohol, marijuana, barbiturates, or opiates in the drug screen are not
exclusionary if, in the investigator's documented opinion, the subject does not meet
DSM-5 criteria for moderate to severe substance use disorder and the positive test
does not signal a clinical condition that would impact the safety of the subject or
interpretation of the trial results, and participation is agreed to by the medical
monitor prior to treatment.

- Treatment with an MAOI within 14 day prior to the first dose of IMP in Phase A.

- Use of benzodiazepines and/or hypnotics (including non-benzodiazepine sleep aids)
within 7 days prior to first dose of IMP in Phase A.

- Use of varenicline within 5 days prior to the first dose of IMP in Phase A.

- Use of oral (or immediate release intramuscular) neuroleptics within 7 days prior or
long-acting approved neuroleptics ≤ 1 full cycle plus 1/2 cycle prior to the first
dose of IMP in Phase A.

- Subjects who would be likely to require prohibited concomitant therapy during the
trial.

- Subjects who have been exposed to brexpiprazole in any prior clinical trial or has
received commercial brexpiprazole (Rexulti).

- Subjects with a history of neuroleptic malignant syndrome or serotonin syndrome.

- Subjects with a history of true allergic response to more than one class of
medications

- Prisoners or subjects who are compulsorily detained for treatment of either a
psychiatric or physical illness.

- Subjects who participated in any clinical trial within the last 60 days or who
participated in more than 2 clinical trials within the past year
We found this trial at
53
sites
Salem, Oregon 97301
Phone: 503-540-0100
?
mi
from
Salem, OR
Click here to add this to my saved trials
One Utah Avenue
Cherry Hill, New Jersey 08002
856-857-9500
?
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
911 E. Hallandale Beach Blvd
Hallandale Beach, Florida 33009
954-455-5757
?
mi
from
Hallandale Beach, FL
Click here to add this to my saved trials
Austin, Texas 78737
?
mi
from
Austin, TX
Click here to add this to my saved trials
Baltimore, Maryland 21208
Phone: 410-602-1440
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
3570 Warrensville Center Road
Beachwood, Ohio 44122
Phone: 216-832-6606
?
mi
from
Beachwood, OH
Click here to add this to my saved trials
115 Mill St
Belmont, Massachusetts 02478
(617) 855-2000
Phone: 617-855-3186
McLean Hospital McLean Hospital is a comprehensive psychiatric hospital committed to providing easy access to...
?
mi
from
Belmont, MA
Click here to add this to my saved trials
Berlin, 10969
Phone: +49302514928
?
mi
from
Berlin,
Click here to add this to my saved trials
Berlin, New Jersey
Phone: 856-753-7335
?
mi
from
Berlin, NJ
Click here to add this to my saved trials
436 North Roxbury Drive
Beverly Hills, California 90210
Phone: 424-284-3171
?
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Boston, Massachusetts 02135
Phone: 617-477-4868
?
mi
from
Boston, MA
Click here to add this to my saved trials
Cedarhurst, New York 11516
Phone: 516-295-7230
?
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
Chicago, Illinois 60634
Phone: 773-282-9845
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Chicago, Illinois 60640
Phone: 773-989-8313
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Cincinnati, Ohio 45242
Phone: 513-791-7760
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Colorado Springs, Colorado 80910
Phone: 719-634-6576
?
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Columbus, Ohio 43210
Phone: 614-293-7109
?
mi
from
Columbus, OH
Click here to add this to my saved trials
Culver City, California 90230
Phone: 424-227-8127
?
mi
from
Culver City, CA
Click here to add this to my saved trials
Decatur, Georgia 30030
Phone: 404-537-1281
?
mi
from
Decatur, GA
Click here to add this to my saved trials
Downingtown, Pennsylvania 19335
Phone: 610-891-9024
?
mi
from
Downingtown, PA
Click here to add this to my saved trials
Flowood, Mississippi 39232
Phone: 601-420-5810
?
mi
from
Flowood, MS
Click here to add this to my saved trials
Garden Grove, California 92845
Phone: 714-799-7799
?
mi
from
Garden Grove, CA
Click here to add this to my saved trials
222 West Eulalia Street
Glendale, California 91204
Phone: 323-644-7884
?
mi
from
Glendale, CA
Click here to add this to my saved trials
Jacksonville, Florida 32216
Phone: 904-281-5757
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Lauderhill, Florida 33319
Phone: 954-990-6326
?
mi
from
Lauderhill, FL
Click here to add this to my saved trials
Lemon Grove, California 91945
Phone: 619-327-0155
?
mi
from
Lemon Grove, CA
Click here to add this to my saved trials
Little Rock, Arkansas 72211
Phone: 501-221-8681
?
mi
from
Little Rock, AR
Click here to add this to my saved trials
Los Alamitos, California 90720
Phone: 714-827-3668
?
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Los Angeles, California 90024
Phone: 310-208-7144
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Madison, Wisconsin 53715
Phone: 608-283-7333
?
mi
from
Madison, WI
Click here to add this to my saved trials
Methuen, Massachusetts 01844
Phone: 978-655-7155
?
mi
from
Methuen, MA
Click here to add this to my saved trials
New York, New York 10168
Phone: 212-722-3570
?
mi
from
New York, NY
Click here to add this to my saved trials
Oakland, California 94612
Phone: 510-444-2877
?
mi
from
Oakland, CA
Click here to add this to my saved trials
Oklahoma City, Oklahoma 73112
Phone: 405-286-2104
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Oklahoma City, Oklahoma 73112
Phone: 405-753-4994
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Orlando, Florida 32806
Phone: 407-425-5100
?
mi
from
Orlando, FL
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
Phone: 215-746-6680
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Portland, Oregon 97210
Phone: 503-273-6224
?
mi
from
Portland, OR
Click here to add this to my saved trials
Redlands, California 92374
Phone: 909-792-9007
?
mi
from
Redlands, CA
Click here to add this to my saved trials
Richardson, Texas 75080
Phone: 214-396-4844
?
mi
from
Richardson, TX
Click here to add this to my saved trials
Rochester Hills, Michigan 48307
Phone: 248-608-8800
?
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
609 West Dyke Road
Rogers, Arkansas 72758
Phone: 479-927-3000
?
mi
from
Rogers, AR
Click here to add this to my saved trials
Saint Louis, Missouri 63141
Phone: 314-771-6387
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Salt Lake City, Utah 84105
Phone: 801-467-1200
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Salt Lake City, Utah 84123
Phone: 801-261-8930
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
San Diego, California 92123
Phone: 858-278-3647
?
mi
from
San Diego, CA
Click here to add this to my saved trials
San Marcos, California 92078
Phone: 760-266-4144
?
mi
from
San Marcos, CA
Click here to add this to my saved trials
Tampa, Florida 33609
Phone: 813-849-5566
?
mi
from
Tampa, FL
Click here to add this to my saved trials
Temecula, California 92591
Phone: 951-695-6238
?
mi
from
Temecula, CA
Click here to add this to my saved trials
Towson, Maryland 21204
Phone: 410-938-3125
?
mi
from
Towson, MD
Click here to add this to my saved trials
Upland, California 91786
Phone: 909-920-3000
?
mi
from
Upland, CA
Click here to add this to my saved trials
521 Mount Auburn Street
Watertown, Massachusetts 02472
Phone: 617-744-8542
?
mi
from
Watertown, MA
Click here to add this to my saved trials
3300 Seymour Highway
Wichita Falls, Texas 76309
Phone: 940-322-1131
?
mi
from
Wichita Falls, TX
Click here to add this to my saved trials